×
×
×
×
×

Tell us once and we'll remember.

I'm an...

Don't worry, you can always change this selection using the icons at the top left of the site.
  

Monetization Beats Momentum

Third Quarter 2026

Key Takeaways
  • Leadership shifted among growth stocks as investors moved away from high-momentum semiconductor names toward companies demonstrating clearer AI monetization, while surging Treasury yields and higher oil prices weighed on cyclical areas of the market.
  • The Strategy outperformed on strong stock selection, as the unwind in AI momentum rewarded our more disciplined, valuation-sensitive approach and software holdings rebounded.
  • We used AI-related volatility to broaden our participation in AI infrastructure through new positions in Advanced Micro Devices, Micron Technology and Vertiv.
Market Overview

U.S. equities saw shifting leadership in the third quarter, with a selloff in higher-beta AI stocks offsetting corporate earnings strength in a period that saw Treasury bond yields rise to multidecade highs. The benchmark Russell 3000 Growth Index rose 0.5%, trailing the 2.3% return of the Russell 3000 Value Index, while mid and small cap growth stocks moved lower.

Within growth, leadership moved away from the semiconductor winners of the first half of 2026 toward hyperscalers and software companies demonstrating clearer paths to AI monetization. The June Russell index reconstitution was also consequential, materially increasing semiconductors’ weight in large cap growth indexes while reducing the weight of software, altering both the benchmark’s character and the relative performance backdrop.

AI was the main source of volatility during the quarter. A sharp momentum selloff in July unwound crowded positions in certain semiconductor and AI-exposed industrial stocks as investors questioned the durability of and payoff from capital spending. These concerns resurfaced in September after a coordinated call among the leading AI labs to slow the pace of frontier model development. Anthropic’s delayed initial public offering and a significant rise in usage of lower-priced open-source models intensified the debate around AI monetization.

Macro forces also shaped sector returns within the benchmark. Continued conflict with Iran drove oil prices higher, making energy the benchmark’s best-performing sector. The Federal Reserve’s first rate increase since 2023 and a sharp rise in Treasury yields weighed on rate-sensitive and cyclical stocks, leaving utilities and industrials, where AI power and infrastructure names also pulled back, as the weakest sectors.

Performance Overview

The ClearBridge All Cap Growth Strategy outperformed its Russell 3000 Growth benchmark during the third quarter, benefiting from strong stock selection as the unwind in AI momentum rewarded our more disciplined, valuation-sensitive approach. Stock selection contributed in seven of the nine sectors in which we were invested, led by IT, industrials and consumer discretionary, and much of the benefit came from what we did not own.

IT was the largest contributor to relative performance. Information security provider CrowdStrike led the way as several of our software holdings rebounded after coming under pressure in the first half of the year. The rebound helped security companies such as Palo Alto Networks and infrastructure software makers like Snowflake, which now appears positioned to benefit from the proliferation of AI agents. Micron Technology, a new position, also contributed, as our purchases came after much of the memory maker’s July decline. Semiconductor equipment makers Applied Materials, KLA and Lam Research, which had surged in the second quarter, fell sharply as crowded AI semiconductor trades unwound, and not owning them contributed meaningfully to relative returns.

Our underweights to Nvidia and Microsoft — a function both of our fundamental views of the companies and position size limits in a concentrated, evolving benchmark — were the largest detractors. Nvidia’s data center revenue continued to grow rapidly, while Microsoft’s shares were supported by continued Azure cloud momentum, encouraging Copilot usage data and signs of recovery in enterprise software during an optimistic period for AI monetization. Broadcom declined with AI semiconductors and after issuing a fiscal fourth-quarter revenue forecast slightly below expectations, and ASML, not in our benchmark, declined with the broader semiconductor capital equipment group as elevated expectations and uncertainty over export controls constrained upside, even as ASML’s second-quarter results were strong.

In industrials, stock selection more than offset the cost of our overweight to one of the benchmark’s weakest sectors. Not owning Caterpillar helped as growing public resistance to data center construction raised questions about the power generation demand behind its earlier rally. However, Axon Enterprise, a maker of TASER devices, body cameras and public safety software, detracted as second-quarter profitability fell and inventory rose.

In consumer discretionary, our underweight to Tesla helped as the stock fell sharply after second-quarter profit missed expectations on lower vehicle prices and higher AI spending. In communication services, Meta Platforms advanced following a strong reception to the launch of its Muse personal AI agent, whose early downloads surpassed those of the ChatGPT and Gemini debuts, reinforcing our view that agentic commerce is becoming a broader opportunity. Also in communication services, AppLovin, which operates a leading AI-powered platform for mobile application marketing and monetization, detracted as an expected step-up in model performance shifted from the second quarter into the third, leaving results short of the company’s own guidance.

 

"The selloff in AI-related stocks created attractive entry points to build positions in companies we had not owned." 

 

In health care, Natera, a leader in molecular residual disease (MRD) testing for cancer recurrence, reported an increase in quarterly MRD test additions and raising its full-year guidance, helping shares rise. Thermo Fisher Scientific, a fully active position, beat earnings, with resilient biopharma consumables and pharmaceutical product development end markets and healthy third-quarter guidance supporting the prospect of an accelerating business into 2027.

Portfolio Positioning

Our portfolio activity during the quarter was guided by two objectives: thoughtfully expanding exposure to AI and semiconductor infrastructure while maintaining appropriate risk following the June Russell reconstitution.

The selloff in AI-related stocks created attractive entry points to build positions in companies we had not owned. We initiated positions in Advanced Micro Devices, which offers differentiated exposure to high-performance computing, and Micron Technology, which holds a particularly strong position in DRAM and high-bandwidth memory. AI data centers require significantly more memory than traditional computing systems, and we see Micron as a differentiated way to gain exposure to the AI buildout while diversifying our semiconductor holdings. We also added Vertiv, which stands to benefit from increasingly power- and cooling-intensive data center architectures. Encouraged by a recovery in software, we added to our position in ServiceNow; our aggregate software exposure remains weighted toward security and infrastructure investments.

We continued to refine our mega cap exposures after the Russell index reconstitution, more than doubling our position in Alphabet and further reducing Amazon and Microsoft. To fund the additions, we exited Roche, a position where our conviction had diminished, and sold e.l.f. Beauty and Tractor Supply as decelerating growth and questions around long-term return potential weakened our confidence. We also sold Insulet on concerns about competition and execution.

Outlook

The recent AI selloff has created a more constructive backdrop for our process. We remain fundamentally positive on AI and believe adoption is still early, but the market had moved quickly into many infrastructure names to capitalize on high expectations. A usage shift from proprietary to open-source models does not diminish the need for compute; in many cases, their broader use reinforces demand for the underlying infrastructure.

Times of change and uncertainty create opportunities for us as bottom-up stock pickers, as the market often has a habit of painting industries and subindustries with a broad brush, as it did when software was sold indiscriminately over much of the last 12 months. Classic measures of market breadth remain weak even as individual business fundamentals are sound, a combination we believe argues for selectivity. We would not be surprised to see bifurcation in the market as earnings reveal the ability for AI to either accelerate near-term business momentum or erode it, and our balance across sectors and the spectrum of growth leaves the Strategy well positioned to identify the winners and losers as AI’s implications broaden.

Portfolio Highlights

The ClearBridge All Cap Growth Strategy outperformed its Russell 3000 Growth Index benchmark during the third quarter. On an absolute basis, the Strategy had positive contributions from five of the nine sectors in which it was invested. The leading contributors were the IT, health care and communication services sectors, while the industrials sector detracted the most.

On a relative basis, overall stock selection contributed to performance, while overall sector allocation detracted. Stock selection in the IT, industrials, consumer discretionary, health care, communication services and materials sectors benefited performance. Conversely, an overweight to the industrials sector weighed on relative results.

On an individual stock basis, the biggest contributors to relative returns were CrowdStrike, Natera and Meta Platforms, as well as not owning Applied Materials and KLA. The largest detractors from relative returns were AppLovin, ASML and Broadcom, as well as underweights to Nvidia and Microsoft.

In addition to the transactions discussed above, we exited positions in Chipotle Mexican Grill in the consumer discretionary sector, Doximity in the health care sector, Builders FirstSource in the industrials sector and Vistra in the utilities sector.

Related Perspectives

Adapting to a Momentum Growth Market
All Cap Growth 2Q26: Activity was focused on rebalancing mega cap exposures and enhancing participation in both higher beta market leadership as well as diversified growth companies in areas like health care.
Growth Pressured by Rotation, Supported by Diversification
All Cap Growth 1Q26: Broad-based weakness in software and health care disruptors drove underperformance, partially offset by strength in semiconductors, materials and select consumer holdings.
Staying Committed through Momentum Rebound
All Cap Growth 2Q25: The Strategy’s more diversified exposure compared to our concentrated benchmark reversed from a tailwind in a turbulent first quarter to a headwind in a risk-on second quarter.
Contributors Beyond Mega Caps Offset Volatility
All Cap Growth 1Q25: We believe the Strategy is well-positioned for a period of heightened uncertainty, with generally lower tariff exposure and holdings beyond the Magnificent Seven starting to deliver better earnings growth.
Being Patient in Momentum Growth Market
All Cap Growth 4Q24: The Strategy was hurt by health care weakness and having less exposure to some of the outperforming, higher-beta growth names in the benchmark.  
MORE

Related Blog Posts

Emerging Markets: Why Waiting for Certainty Could Be Costly
Emerging markets have significantly evolved in recent years and offer a more compelling risk/reward setup than in the past. From deeper local markets to world-leading companies, EM presents a stronger opportunity than geopolitical volatility suggests.
Energy Hedges the AI Trade
While the AI trade absorbs nearly all available investor attention, owning energy covers our absolute risk while creating the risk budget to cover the AI relative risk more effectively.
A Broader Market, a Stronger Case for Dividend Growth
High-quality dividend growers outside technology offer attractive income, inflation offsets and downside protection as momentum in AI-related stocks shows signs of fatigue.
AOR Update: Are Higher Rates a "Real" Problem?
Higher yields appear less threatening when viewed against the resilient economic and earnings backdrop along with the green ClearBridge U.S. Recession Dashboard.
Health Care’s Next Act: R&D Tailwinds Emerging
Drug development appears to be stabilizing, as improving biopharma funding and healthier demand create a more constructive backdrop for contract research organizations and life science tools companies.
MORE
  • Past performance is no guarantee of future results. Copyright © 2026 ClearBridge Investments. All opinions and data included in this commentary are as of the publication date and are subject to change. The opinions and views expressed herein are of the author and may differ from other portfolio managers or the firm as a whole, and are not intended to be a forecast of future events, a guarantee of future results or investment advice. This information should not be used as the sole basis to make any investment decision. The statistics have been obtained from sources believed to be reliable, but the accuracy and completeness of this information cannot be guaranteed. Neither ClearBridge Investments, LLC  nor its information providers are responsible for any damages or losses arising from any use of this information.

  • Source: London Stock Exchange Group plc and its group undertakings (collectively, the “LSE Group”). © LSE Group 2026. FTSE Russell is a trading name of certain of the LSE Group companies. “Russell®” is a trade mark of the relevant LSE Group companies and is/are used by any other LSE Group company under license. All rights in the FTSE Russell indexes or data vest in the relevant LSE Group company which owns the index or the data. Neither LSE Group nor its licensors accept any liability for any errors or omissions in the indexes or data and no party may rely on any indexes or data contained in this communication. No further distribution of data from the LSE Group is permitted without the relevant LSE Group company’s express written consent. The LSE Group does not promote, sponsor or endorse the content of this communication.

  • Performance source: Internal. Benchmark source: Standard & Poor's.

more